Australia's most trusted
source of pharma news
Tuesday, 10 February 2026
Tuesday, 10 February 2026
Subscribe
Login
News Headlines
News Headlines
News
GLP-1 blockbuster finally hits NZ
Posted 10 February 2026 AM
Eli Lilly’s Mounjaro has finally been approved for use in New Zealand, with the company’s sights now on securing government funding – and it’s starting with type 2 diabetes.
After being reviewed under the Medsafe priority review pathway, the once-weekly injectable is now available on private prescription in all dosages, at a recommended retail price starting from $410 NZD (2.5 mg). It is the first and only dual GLP-1 and GIP receptor agonist registered in New Zealand.
To see the whole article, please login
Posted 10 February 2026 AM
Eli Lilly’s Mounjaro has finally been approved for use in New Zealand, with the company’s sights now on securing government funding – and it’s starting with type 2 diabetes.
After being reviewed under the Medsafe priority review pathway, the once-weekly injectable is now available on private prescription in all dosages, at a recommended retail price starting from $410 NZD (2.5 mg). It is the first and only dual GLP-1 and GIP receptor agonist registered in New Zealand.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (3)
- Marketing Manager - Sydney
- Senior Brand Manager - Sydney
- Business Analyst / Product Owner – Digital Health (EMR) - Melbourne
Sales & Customer Relations (12)
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Customer Service Representative - St Leonards
- Hospital Sales Representative - Melbourne
- Sales & Key Account Associate - Melbourne
- Senior Territory Sales Manager - Melbourne
- Customer Service Representative - Pemulwuy
- Inside Sales Specialist - Melbourne
- Key Account Manager - CNS - Sydney
- Pharmaceutical Sales Representative - Gold Coast
- GP Sales Representative - Brisbane
- Clinical Research, Business Development Manager - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Access & Reimbursement (1)
Clinical & Medical, R&D (7)
- Medical Advisor - Sydney
- Head of Medical - Sydney
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Clinical Research, Business Development Manager - Shanghai, China
- Senior Project Director - Clinical Research - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (4)
- Senior Quality Assurance Associate - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Regulatory Specialist - Melbourne
- Senior Technical & Regulatory Associate - Sydney
Other (19)
- Pharmacy Assistant - Toongabbie
- QC Analyst -Biochemistry - Melbourne
- SAP Project Lead - Brisbane
- Logistics Manager - Sydney
- Finance Manager - Melbourne
- Senior Recruitment Consultant - Victoria
- Recruitment Consultant - Sydney
- Distribution and Warehouse Technician - Broadmeadows
- Logistics Specialist - Macquarie Park
- Warehouse Associate - Chatswood
- Chief Operating Officer - Sydney
- Chief Operating Officer - Sydney
- Dedicated Principal Agent - Pemulwuy
- Finance Administrator - Sydney
- GP Rep Bundaberg Contract - Bundaberg
- Warehouse & Logistics Officer - Macquarie Park
- Commercial Lead - Melbourne
- Commercial Lead - Melbourne
- Senior Payroll Officer - 41808-1 - Melbourne
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.